États-Unis · Plateformes & données · The Motley Fool

Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push?

Publié par The Motley Fool · États-Unis il y a 10 h

Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push? — Hims & Hers Stock Just Plummeted 17%. Is the Stock a Buy Ahead of a Peptide Push? · The Motley Fool

Résumé détaillé

Hims & Hers stock crashed after issuing weak guidance.

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

À lire aussi

Dynatrace Sees AI Customers Consuming Its Platform at Twice the Rate, Fueling Growth Hopes

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Ceribell director William Burke sells $479,479 in stock

Canagold Resources GAAP EPS of $0.00

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker

Hyperliquid Whales Flip Bullish On Bitcoin After Two Weeks of Shorts: Report